Authors
Dominik Morlok, Jana Rüter, Mona Illmann, Laura Bieniosek, Christine Welker, Melanie Reitz, Janina Meuer, Thomas Okon, Hansjörg Baurecht, Wolfgang Herr, Tobias Pukrop, Mirko Brandes, Anika Berling-Ernst, Louisa Sell, Wiebke Jensen, Rebecca Zimmer, Heike Schmidt, Florian Wagemann, Renee Stark, Annalena Kleinhenz, Bernardine Madl, Hajo Zeeb, Michael Leitzmann, Freerk T Baumann, Anne Herrmann, IMPLEMENT consortium
Published in
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Volume 34. Issue 8. Jul 14, 2026. Epub Jul 14, 2026.
Abstract
Oncological exercise therapy (OET) can enhance physical function and psychosocial well-being of cancer patients. Despite this, OET is still not routinely implemented in cancer care. To address this gap, our study analyzes cancer patients' perspectives on facilitators and barriers for OET participation.
This qualitative study employed semi-structured focus groups and was conducted within the IMPLEMENT research consortium. Focus groups were audio-recorded, transcribed verbatim, and analyzed using framework analysis.
Thirty cancer patients (mean age 57 ± 7 years; 53% women) participated, and most were diagnosed with breast cancer (20%), lymphoma or leukemia (20%), or pancreatic cancer (13%). Participants reported being motivated to become physically active, even when no OET was available. However, they received limited information about physical activity (PA), specifically about OET. They also felt there was a lack of OET offers from healthcare providers. Participation could be increased by improved accessibility involving informational and structural factors, fostering adherence by higher perceived safety and self-efficacy, and by providing individually tailored and low-threshold information for patients.
OET could be a valuable opportunity to support patients throughout their cancer trajectory. To increase participation and promote PA uptake, individually tailored support should be provided in terms of personalized guidance by healthcare practitioners and easily accessible OET offers.
German Clinical Trial Register (Deutsches Register Klinischer Studien-DRKS 00032292), registered 19/07/2023. Clinical Trials Registry (NCT06496711), registered 22/05/2024. Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum (BZKF) DZ-2024-2165-9), registered 07/06/2024.
PMID:
42446746
Bibliographic data and abstract were imported from PubMed on 14 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0